SEP 21, 2022 3:00 AM PDT

Technology for Monitoring Tumors in Pre-Clinical Studies

WRITTEN BY: Katie Kokolus

Pre-clinical modeling, often using laboratory mice, is essential in developing life-saving therapies to treat cancer and other diseases.  While mouse models remain a necessary component in translational research, they cannot mimic all aspects of human disease accurately.  Thus, improving mouse models to more accurately represent human disease would significantly enhance and expedite drug development. 

One challenge of working with mouse cancer models is obtaining precise tumor growth measurements.  Researchers often use calipers that manually measure two dimensions of a murine tumor, but this method is open to unintentional user bias.  While researchers can perform advanced imaging methods on laboratory mice, such as magnetic resonance imaging (MRI), these techniques only provide low-resolution measurement capability.  Further, many advanced tools available for monitoring tumor growth in mice often prove time-consuming and expensive.  Importantly, most imaging technologies available for mice require anesthetization which, notably, is typically not necessary when using similar methods in patients. 

A new study published in Science Advances has demonstrated a unique approach to continuously monitoring the growth or regression of murine tumors in the micrometer range.  This technology, referred to as FAST (flexible autonomous sensors measuring tumor volume regression), wraps around a tumor near the animal's skin and provides researchers with a wealth of essential data. 

The flexible electronic sensor conforms to the mouse and detects strain induced by a growing, or shrinking, tumor providing regular measurements to the researchers.  The authors describe how this method offers three improvements over standard murine tumor measurements.  First, FAST records measurements every five minutes providing a complete picture of tumor growth over time, allowing researchers to know how quickly an investigational treatment works.  Such measurement frequency remains highly infeasible by any standard methods of monitoring murine tumor growth.  Second, the authors explain that the sensor improves measurement accuracy by distinguishing changes in tumor size too small to detect with standard methods.  Third, FAST is autonomous and noninvasive, further enhancing the ability to achieve an accurate picture of tumor regression while subjecting the animal to minimal stress or discomfort.

The authors conclude that the ability of FAST to continuously, autonomously, and accurately monitor changes in tumor volume makes it an excellent candidate to replace current tumor measurement methods.  This technology can significantly improve pre-clinical research strategies by providing high-throughput screening of novel drugs under development.  This technology may expedite the generation of new drugs that will benefit cancer patients and extend survival. 

 

Sources: Dis Model Mech, Sci Transl Med, Sci Advances

About the Author
PhD
PhD in Tumor Immunology. I am interested in developing novel strategies to improve the efficacy of immunotherapies used to extend cancer survivorship.
You May Also Like
APR 26, 2022
Clinical & Molecular DX
A Blood Test Could Detect Cancer Before a CT Scan or MRI
APR 26, 2022
A Blood Test Could Detect Cancer Before a CT Scan or MRI
  As cancer cells grow and divide, their DNA is released into the bloodstream. This DNA, called ctDNA (circulating ...
JUN 09, 2022
Cancer
A Case Study May Identify a Novel Gene Therapy for Pancreatic Cancer
JUN 09, 2022
A Case Study May Identify a Novel Gene Therapy for Pancreatic Cancer
Pancreatic ductal adenocarcinoma (PDAC) is a very aggressive pancreatic cancer with limited treatment options.  PDA ...
JUN 21, 2022
Cancer
Advanced Lung Cancer Diagnosis Linked to Socioeconomic Status
JUN 21, 2022
Advanced Lung Cancer Diagnosis Linked to Socioeconomic Status
Lung cancer remains the leading cause of cancer-related deaths for both males and females, and an estimated 120,000 peop ...
JUL 21, 2022
Cancer
Can Microrobots Deliver Chemotherapy Directly to a Tumor?
JUL 21, 2022
Can Microrobots Deliver Chemotherapy Directly to a Tumor?
Microrobotics, also called microbotics, is a field of study focusing on miniature robotics capable of carrying tiny comp ...
AUG 29, 2022
Cancer
Could Robotic Surgery Provide Better Care for Patients with Kidney Cancer?
AUG 29, 2022
Could Robotic Surgery Provide Better Care for Patients with Kidney Cancer?
Renal cell carcinoma (RCC) is the most common type of kidney cancer, accounting for about 90% of kidney cancer incidence ...
SEP 15, 2022
Cancer
Early-Onset Cancers are Rising: Do We Know Why?
SEP 15, 2022
Early-Onset Cancers are Rising: Do We Know Why?
Early-onset cancers, typically defined as those diagnosed in people aged approximately 20 - 50, have continually increas ...
Loading Comments...